150 related articles for article (PubMed ID: 1783913)
21. Visual stimulation increases technetium-99m-HMPAO distribution in human visual cortex.
Woods SW; Hegeman IM; Zubal IG; Krystal JH; Koster K; Smith EO; Heninger GR; Hoffer PB
J Nucl Med; 1991 Feb; 32(2):210-5. PubMed ID: 1992020
[TBL] [Abstract][Full Text] [Related]
22. Quantitation of rCBF by 99mTc-hexamethylpropyleneamine oxime single photon emission computed tomography combined with 133Xe CBF.
Isaka Y; Itoi Y; Imaizumi M; Ashida K; Okamoto M; Iiji O
J Cereb Blood Flow Metab; 1994 Mar; 14(2):353-7. PubMed ID: 8113331
[TBL] [Abstract][Full Text] [Related]
23. 99mTc-HMPAO as a tracer of cerebral blood flow in newborn infants.
Børch K; Greisen G
J Cereb Blood Flow Metab; 1997 Apr; 17(4):448-54. PubMed ID: 9143227
[TBL] [Abstract][Full Text] [Related]
24. 'Normal' 99mTc-HmPAO distribution in large subacute middle cerebral artery infarct.
Steinling M; Huglo D; Kolesnikov H; Vergnes R; Rousseaux M
Stroke; 1994 Dec; 25(12):2507-8. PubMed ID: 7974601
[No Abstract] [Full Text] [Related]
25. 99mTc-D,L-hexamethylene-propyleneamine oxime (99mTc-HMPAO): basic kinetic studies of a tracer of cerebral blood flow.
Andersen AR
Cerebrovasc Brain Metab Rev; 1989; 1(4):288-318. PubMed ID: 2701656
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of increased uptake of HMPAO on brain SPECT scans in acute stroke.
Alexandrov AV; Ehrlich LE; Bladin CF; Black SE
J Neuroimaging; 1996 Jul; 6(3):150-5. PubMed ID: 8704289
[TBL] [Abstract][Full Text] [Related]
27. Validation to eliminate vascular activity on 99Tcm-HMPAO brain SPECT for regional cerebral blood flow (rCBF) determination.
Hayashida K; Nishimura T; Imakita S; Uehara T
Nucl Med Commun; 1991 Jun; 12(6):545-50. PubMed ID: 1866107
[TBL] [Abstract][Full Text] [Related]
28. Toward absolute quantitation of cerebral blood flow using technetium-99m-HMPAO and a single scan.
Rattner Z; Smith EO; Woods S; Dey H; Hoffer PB
J Nucl Med; 1991 Aug; 32(8):1506-7. PubMed ID: 1869969
[No Abstract] [Full Text] [Related]
29. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
[TBL] [Abstract][Full Text] [Related]
30. [Difference in the distribution of 123I-IMP and 99mTc-HMPAO in the striatum--comparison with 15O-PET].
Otsuka M; Ichiya Y; Kuwabara Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
Kaku Igaku; 1993 Apr; 30(4):389-95. PubMed ID: 8315889
[TBL] [Abstract][Full Text] [Related]
31. Hyperfixation of HMPAO in subacute ischemic stroke leading to spuriously high estimates of cerebral blood flow by SPECT.
Sperling B; Lassen NA
Stroke; 1993 Feb; 24(2):193-4. PubMed ID: 8421817
[No Abstract] [Full Text] [Related]
32. Regional cerebral blood flow changes in stroke imaged by Tc-99m HMPAO SPECT with corresponding anatomic image comparison.
Mountz JM; Deutsch G; Khan SH
Clin Nucl Med; 1993 Dec; 18(12):1067-82. PubMed ID: 8293629
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of neuro-Behçet disease with 99mTc-HMPAO brain SPECT: comparison with MR imaging].
Kikuchi Y; Oshima M; Sasaki Y; Kaminaga T; Ban S; Shirai T; Yokokawa T; Higashi S; Yasukouchi H; Furui S
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jul; 57(8):515-9. PubMed ID: 9267141
[TBL] [Abstract][Full Text] [Related]
34. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates.
Dormehl IC; Oliver DW; Langen KJ; Hugo N; Croft SA
J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465
[TBL] [Abstract][Full Text] [Related]
35. [Intrasubject comparison of regional cerebral blood flow between N-isopropyl-p-[123I]iodoamphetamine SPECT and 99mTc-hexamethylpropyleneamine oxime SPECT in patients with ischemic cerebrovascular disease].
Isaka Y; Yoshikawa T; Ohe Y; Nakayama H; Abe T; Ashida K; Imaizumi M; Tanaka S
Kaku Igaku; 1995 Feb; 32(2):131-8. PubMed ID: 7715098
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m-HMPAO SPECT in Sturge-Weber syndrome.
Bar-Sever Z; Connolly LP; Barnes PD; Treves ST
J Nucl Med; 1996 Jan; 37(1):81-3. PubMed ID: 8544008
[TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study.
Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA
J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175
[TBL] [Abstract][Full Text] [Related]
38. [Raise up 99mTc-HMPAO brain SPECT for detecting the changes in cerebral perfusion pressure].
Hayashida K; Nishimura T; Uehara T; Kaminaga T; Hirose Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jul; 52(7):1036-8. PubMed ID: 1508649
[TBL] [Abstract][Full Text] [Related]
39. Discordant technetium-99m HMPAO and thallium-201 chloride distribution in brain tumors.
Kamisaki Y; Seto H; Nagayoshi T; Kageyama M; Shimizu M; Wu YW; Watanabe N; Kakishita M
Radiat Med; 1996; 14(3):155-8. PubMed ID: 8827811
[TBL] [Abstract][Full Text] [Related]
40. 99Tcm-HMPAO SPET and cerebral blood flow: a study of CO2 reactivity.
Choksey MS; Costa DC; Iannotti F; Ell PJ; Crockard HA
Nucl Med Commun; 1989 Aug; 10(8):609-18. PubMed ID: 2510102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
